Streetbeat News

Revenues

EDU

Shares of New Oriental (EDU) are up following the company's report of Q2 sales that exceeded expectations. Additionally, the company provided guidance for Q3.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:15 pm

BOKF

In the last three months, 4 analysts have provided ratings on BOK Financial (NASDAQ:BOKF), all maintaining an 'Indifferent' stance. The average 12-month price target is $90.75, with a high of $98.00 and a low of $78.00. The current average target has decreased by 1.71% from the previous $92.33. BOK Financial's financial performance shows a -1.28% decline in revenue growth, a high net margin of 27.27%, an ROE of 2.76%, and an ROA of 0.27%, but a concerning debt-to-equity ratio of 1.31.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:01 pm

ELV

Elevance Health (NYSE:ELV) has received mixed analyst ratings over the past three months, with 4 somewhat bullish ratings. The average 12-month price target is $555.00, with a high of $574.00 and a low of $547.00, reflecting a 2.72% decrease from the previous average. Analysts from RBC Capital, Cantor Fitzgerald, and JP Morgan have provided updates, with actions ranging from maintaining to raising and lowering ratings and price targets. Elevance Health is a major health insurer in the U.S. with significant market capitalization, revenue growth, and financial performance indicators such as net margin, ROE, and ROA, but carries a higher debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:01 pm

SLM

SLM Corp (NASDAQ:SLM) has been analyzed by 9 analysts, showing diverse opinions with an average 12-month price target of $20.28, up 16.55% from the previous $17.40. Recent actions by analysts include raised price targets and ratings, indicating a positive outlook. Despite this, SLM faces financial challenges with a -12.0% revenue decline, below-average net margin, ROE, and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:01 pm

RYTM

Rhythm Pharmaceuticals (NASDAQ:RYTM) has received 7 analyst ratings in the past quarter, with a consensus 12-month price target of $48.14, up from $38.86. Analysts from Goldman Sachs, Needham, Morgan Stanley, and Wells Fargo have raised their price targets, reflecting a bullish sentiment. The company's financials show a significant revenue growth rate of 425.3% and a high net margin of -196.25%, but a lower ROA of -13.3%. RYTM is engaged in developing therapies for rare diseases and obesity caused by MC4 pathway deficiencies.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:00 pm

PB

Prosperity Bancshares (NYSE:PB) has been reviewed by 5 analysts over the past three months, with a mix of opinions. Recent ratings show 4 bullish and 1 indifferent stance, with no bearish views. The average 12-month price target is $72.8, a 14.34% increase from the previous $63.67. Analysts from RBC Capital, Raymond James, Truist Securities, UBS, and Citigroup have provided updates, with most raising their price targets. Prosperity Bancshares operates a community bank model in Texas and has seen a -6.47% decline in revenue growth as of September 30, 2023. Despite this, the company has a high net margin of 41.97% but a lower ROE of 1.6% and an above-average debt-to-equity ratio of 0.6.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:00 pm

PRTA

Prothena Corp (NASDAQ:PRTA) has received mixed analyst ratings over the past three months, with 1 bullish, 3 somewhat bullish, and 1 indifferent. The average 12-month price target is $79.0, down from $85.00, with a high of $129.00 and a low of $36.00. Analysts from RBC Capital, Cantor Fitzgerald, Deutsche Bank, and JMP Securities have adjusted their ratings and price targets. Prothena's financial performance shows a revenue growth of 5494.33%, a net margin of 25.81%, an ROE of 3.65%, an ROA of 2.99%, and a low debt-to-equity ratio of 0.02.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:00 pm

SHW

Sherwin-Williams Company (NYSE:SHW) reported Q4 revenue of $5.252 billion, surpassing the consensus of $5.220 billion, with a 0.4% year-over-year growth. Adjusted EPS was $1.81, beating the $1.80 consensus. The company saw an increase in Paint Stores Group net sales volume, a gross profit rise to $2.548 billion, and a gross margin expansion to 48.5%. Full-year sales reached a record $23.05 billion, with an adjusted net income per share increase of 18.6% to $10.35. Sherwin-Williams forecasts FY24 adjusted EPS of $10.85-$11.35, against an analyst consensus of $11.33, and expects Q1 2024 consolidated net sales to change by a low-single-digit percentage year-over-year. SHW shares dropped 1.39% to $297.02.

Portfolio Pulse from Nabaparna Bhattacharya

January 25, 2024 | 5:00 pm

LVMHF

LVMH Moet Hennessy Louis Vuitton reported a 2023 revenue of €86.15 billion, representing a 13% organic growth year-over-year. The company's profit from recurring operations reached €22.8 billion.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 4:50 pm

BLK

BTCUSD

Stefan Rust, founder of Truflation and former CEO of Bitcoin.com, stated in Benzinga's Crypto Webinar that there is demand for cryptocurrencies, leading to firms like BlackRock and Fidelity engaging in the space and adding credibility to the market.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 4:41 pm